Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8939)
All Articles published online
|
Publishing Process of This Article
|
Nov 18, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mohamed AA, Elbedewy TA, El-Serafy M, El-Toukhy N, Ahmed W, Ali El Din Z. Hepatitis C virus: A global view. World J Hepatol 2015; 7(26): 2676-2680 [PMID: 26609344 DOI: 10.4254/wjh.v7.i26.2676] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i26/2676.htm |
| Number | Citing Articles |
| 1 |
EL-Shahat A. Toson, Gamal E. Shiha, Asmaa E. Abdelgaleel. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Annals of Hepatology 2017; 16(6): 862 doi: 10.5604/01.3001.0010.5276
|
| 2 |
Komal Saleem, Braira Wahid, Amjad Ali, Shazia Rafique, Zara Naz, Sana Usman, Muhammad Idrees. Unexpected Response Profiles Seen in Hepatitis C Virus-Infected Patients Treated with Sofosbuvir Plus Ribavirin: Five Case Reports. Viral Immunology 2018; 31(6): 480 doi: 10.1089/vim.2017.0199
|
| 3 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1): 40 doi: 10.2337/cd18-0112
|
| 4 |
Lap P. Nguyen, Chorong Park, Trang T. D. Luong, Eun-Mee Park, Dong-Hwa Choi, Kang Min Han, Han N. Mai, Huu C. Nguyen, Yun-Sook Lim, Soon B. Hwang. 5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43783-6
|
| 5 |
Yusheng Jie, Chaoshuang Lin, Jing Yuan, Zhixin Zhao, Yujuan Guan, Yuanping Zhou, Xiaohui Zhou, Bihui Zhong, Yinong Ye, Lihua Zhang, Ling Tao, Jianping Li, Xiaohong Zhang, Yutian Chong. Real-world effectiveness and safety of OBT/PTV/r and dasabuvir for patients with chronic HCV genotype 1b infection in China: A multicenter prospective observational study. Liver Research 2020; 4(3): 153 doi: 10.1016/j.livres.2020.06.002
|
| 6 |
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico Approach. International Journal of Peptide Research and Therapeutics 2019; 25(3): 861 doi: 10.1007/s10989-018-9735-4
|
| 7 |
Xue Yang, Yan Ye, Tingting Wang, Mei Li, Lei Yu, Min Xia, Jun Qian, Zhigang Hu. Eu3+/Sm3+ dual‐label time‐resolved fluoroimmunoassay for measurement of hepatitis C virus antibodies. Journal of Clinical Laboratory Analysis 2019; 33(2) doi: 10.1002/jcla.22659
|
| 8 |
Xin Zheng, Rui Guo, Qingbo Liu, Kousho Wakae, Noriyuki Watanabe, Kento Fukano, Lusheng Que, Yingfang Li, Hussein H. Aly, Koichi Watashi, Ryosuke Suzuki, Asako Murayama, Takanobu Kato, Hideki Aizaki, Takaji Wakita, Xiaoxiao Huang, Yi Yan, Shao-Jiang Song, Masamichi Muramatsu. Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus. Biochemical and Biophysical Research Communications 2021; 567: 1 doi: 10.1016/j.bbrc.2021.06.022
|
| 9 |
Jin-Ching Lee, Chun-Kuang Lin, Chin-Kai Tseng, Yeh-Long Chen, Cherng-Chyi Tzeng, Chih-Hua Tseng. Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV Agents. Molecules 2018; 23(11): 2863 doi: 10.3390/molecules23112863
|
| 10 |
Zeinab Ashour, Rasha Shahin, Zeinab Ali-Eldin, Mohamed El-Shayeb, Tarek El-Tayeb, Salwa Bakr. Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00501-4
|
| 11 |
Altay Kandemir, Belkıs Ünsal. Kronik hepatit C tedavisine yanıtı tahmin etmede IL28B gen polimorfizmi. Pamukkale Medical Journal 2018; doi: 10.31362/patd.428482
|
| 12 |
Sidra Rafiq, Muhammad Irfan Majeed, Haq Nawaz, Nosheen Rashid, Umer Yaqoob, Fatima Batool, Saba Bashir, Saba Akbar, Muhammad Abubakar, Shamsheer Ahmad, Saqib Ali, Muhammad Kashif, Imran Amin. Surface-enhanced Raman spectroscopy for analysis of PCR products of viral RNA of hepatitis C patients. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 259: 119908 doi: 10.1016/j.saa.2021.119908
|
| 13 |
Lei Qin, Yan-Cai Zhou, Hong-Jie Wu, Ya Zhuo, Yan-Ping Wang, Chang-Yun Si, Yong-Mei Qin. Notch Signaling Modulates the Balance of Regulatory T Cells and T Helper 17 Cells in Patients with Chronic Hepatitis C. DNA and Cell Biology 2017; 36(4): 311 doi: 10.1089/dna.2016.3609
|
| 14 |
Hamid Heidarian Miri, Pooria Fazeli, Mohammad Ali-Hassanzadeh, Peyman Bemani, Dieter Kabelitz, Kurosh Kalantar. Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. Archives of Virology 2021; 166(9): 2469 doi: 10.1007/s00705-021-05141-8
|
| 15 |
Nehal Shukla, Anastasia Angelopoulou, Rania Hodhod. Non-Invasive Diagnosis of Liver Fibrosis in Chronic Hepatitis C using Mathematical Modeling and Simulation. Electronics 2022; 11(8): 1260 doi: 10.3390/electronics11081260
|
| 16 |
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO® telementoring model for the treatment of patients with hepatitis C. Journal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
|
| 17 |
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
|
| 18 |
Khair Ahammed, Md. Shahriare Satu, Md. Imran Khan, Md Whaiduzzaman. Predicting Infectious State of Hepatitis C Virus Affected Patient's Applying Machine Learning Methods. 2020 IEEE Region 10 Symposium (TENSYMP) 2020; : 1371 doi: 10.1109/TENSYMP50017.2020.9230464
|
| 19 |
Heba Mamdouh Farghaly, Mahmoud Y. Shams, Tarek Abd El-Hafeez. Hepatitis C Virus prediction based on machine learning framework: a real-world case study in Egypt. Knowledge and Information Systems 2023; 65(6): 2595 doi: 10.1007/s10115-023-01851-4
|
| 20 |
Mohammad Taher Bahrami, Bahareh Mohammadi, Shahram Miraghaei, Atefeh Babaei, Matin Ghaheri, Gholamreza Bahrami. Quantification of sofosbuvir in human serum by liquid chromatography with negative ionization mass spectrometry using the parent peak and its source-induced fragment: Application to a bioequivalence study. Journal of Separation Science 2016; 39(14): 2702 doi: 10.1002/jssc.201501375
|
| 21 |
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana. Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI. Revista Colombiana de Gastroenterología 2019; 34(3): 277 doi: 10.22516/25007440.322
|
| 22 |
Chen-Jei Tai, Alagie Jassey, Ching-Hsuan Liu, Cheng-Jeng Tai, Christopher D. Richardson, Shu Hui Wong, Liang-Tzung Lin. Targeting Autophagy Augments Berberine-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA. Cells 2020; 9(4): 908 doi: 10.3390/cells9040908
|
| 23 |
Ebtisam Boushi, Khaled Cheha, Noha Hedar, Rasha Almokdad, Mohammed Waleed Alassi, Ameer Kakaje. Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00150-3
|
| 24 |
Raquel Navarro Sempere, Armando Arias. Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides. Viruses 2019; 11(6): 560 doi: 10.3390/v11060560
|
| 25 |
Hyun Jung Jo, Gyu Nam Park, Hye Ran Kim, Min Ju Kim, Kyung A Shin, Seung Bok Hong, Kyung Soo Chang. Differences in Hematological Characteristics, Including Cholesterol and Apolipoprotein B and E, between Hepatitis B Virus and Hepatitis C Virus Patients in Korea. Journal of Bacteriology and Virology 2016; 46(3): 152 doi: 10.4167/jbv.2016.46.3.152
|
| 26 |
Linh Thuy Nguyen, Dzung Van Nguyen, Michael J. Carr, William W. Hall, Lan Anh Nguyen. Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection. Archives of Virology 2018; 163(1): 115 doi: 10.1007/s00705-017-3583-y
|
| 27 |
Yen-Chieh Lee, Jiun-Ling Wang, Yaa-Hui Dong, Hsi-Chieh Chen, Li-Chiu Wu, Chia-Hsuin Chang, Amit Singal. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study. PLOS Medicine 2019; 16(9): e1002894 doi: 10.1371/journal.pmed.1002894
|
| 28 |
Micah Oyaro, John Wylie, Chien-Yu Chen, Raphael O. Ondondo, Anna Kramvis. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. Southern African Journal of HIV Medicine 2018; 19(1) doi: 10.4102/sajhivmed.v19i1.737
|
| 29 |
Mohamed Gad, Said A. Hassan, Hala E. Zaazaa, Sawsan M. Amer. Multivariate Development and Optimization of Stability Indicating Method for Determination of Daclatasvir in Presence of Potential Degradation Products. Chromatographia 2019; 82(11): 1641 doi: 10.1007/s10337-019-03793-y
|
| 30 |
Zbigniew Wyżewski, Weronika Świtlik, Matylda Barbara Mielcarska, Karolina Paulina Gregorczyk-Zboroch. The Role of Bcl-xL Protein in Viral Infections. International Journal of Molecular Sciences 2021; 22(4): 1956 doi: 10.3390/ijms22041956
|
| 31 |
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
|
| 32 |
Hend Naguib, Shady Fouad Abouelnaga, Mohamed Mamdouh Elsayed. Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?. International Urology and Nephrology 2023; 56(1): 217 doi: 10.1007/s11255-023-03621-1
|
| 33 |
Pratichi Singh, J. Febin Prabhu Dass. Nearly neutral evolution in IFNL3 gene retains the immune function to detect and clear the viral infection in HCV. Progress in Biophysics and Molecular Biology 2018; 140: 107 doi: 10.1016/j.pbiomolbio.2018.05.004
|
| 34 |
Elsayed Elbadrawy, Mona Y. Mostafa. Antioxidant, anti-inflammatory, antimicrobial, and anticancer properties of green broad bean pods (Vicia faba L.). Foods and Raw Materials 2024; 12(2): 308 doi: 10.21603/2308-4057-2024-2-610
|
| 35 |
Jun Fu, Yanyan Li, Zhanzhan Li, Na Li. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma. Bioscience Reports 2018; 38(5) doi: 10.1042/BSR20180044
|
| 36 |
Gusti Rizaldi, Achmad Fuad Hafid, Tutik Sri Wahyuni. Promising alkaloids and flavonoids compounds as anti-hepatitis c virus agents: a review. Journal of Public Health in Africa 2023; doi: 10.4081/jphia.2023.2514
|
| 37 |
Muhammad Junaid Azhar, Noor Khalid, Shanza Azhar, Umer Irshad, Hassaan Ahmed, Tayyab Mumtaz Khan, Samat Habib , Zuha Ali, Yumnah Anwar, Muhammad Bilal. Study of the Effect of Different Hepatitis C Virus Genotypes on Splenomegaly. Cureus 2020; doi: 10.7759/cureus.10164
|
| 38 |
Tahani Amer, Rizk El-Baz, Abdel-Rahman Mokhtar, Saad El-Shaer, Rami Elshazli, Ahmad Settin. Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma. Archives of Physiology and Biochemistry 2017; 123(5): 279 doi: 10.1080/13813455.2017.1320680
|
| 39 |
Thomas J. Marrie, Gregory J. Tyrrell, Sumit R. Majumdar, Dean T. Eurich. Concurrent Infection with Hepatitis C Virus andStreptococcus pneumoniae. Emerging Infectious Diseases 2017; 23(7): 1118 doi: 10.3201/eid2307.161858
|
| 40 |
A.-Mei Zhang, Cheng-Lin Zhang, Yuzhu Song, Ping Zhao, Yue Feng, Binghui Wang, Zheng Li, Li Liu, Xueshan Xia. Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China. International Journal of Infectious Diseases 2016; 53: 6 doi: 10.1016/j.ijid.2016.10.007
|
| 41 |
Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Jerzy Nowak, Iwona Bereszyńska, Ewelina Gowin, Jacek Wysocki, Jolanta Rembowska, Dominika Barcińska, Iwona Mozer-Lisewska, Danuta Januszkiewicz-Lewandowska. Prevalence of <i>IFNL3</i> rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C. World Journal of Gastroenterology 2017; 23(21): 3815-3824 doi: 10.3748/wjg.v23.i21.3815
|
| 42 |
N. Y. Mapoure, M. N. Budzi, S. A. F. B. Eloumou, A. Malongue, C. Okalla, H. N. Luma, Yury E Khudyakov. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLOS ONE 2018; 13(3): e0192406 doi: 10.1371/journal.pone.0192406
|
| 43 |
Mainga Onchong’a Robert, Odari Okoth Eddy, Borus Kimutai Peter, Ole Kwallah Allan, Murithi Gikunda James, Osero Ong’ondo Bernard, Ruttoh Kiplangat Vincent, Mwandawiro Smiti Charles, Lihana Wekesa Raphael. Characterization of Hepatitis C virus circulating among injecting drug users (IDU) in Kilifi county, Kenya. Journal of Human Virology & Retrovirology 2020; 8(2): 23 doi: 10.15406/jhvrv.2020.08.00217
|
| 44 |
Suresh Misra, Douglas T. Dieterich, Behnam Saberi, Tatyana Kushner. Direct-acting antiviral treatment of acute hepatitis C virus infections. Expert Review of Anti-infective Therapy 2018; 16(8): 599 doi: 10.1080/14787210.2018.1505502
|
| 45 |
Taher M. Ghazal, Marrium Anam, Mohammad Kamrul Hasan, Muzammil Hussain, Muhammad Sajid Farooq, Hafiz Muhammad Ammar Ali, Munir Ahmad, Tariq Rahim Soomro. Hep-Pred: Hepatitis C Staging Prediction Using Fine Gaussian SVM. Computers, Materials & Continua 2021; 69(1): 191 doi: 10.32604/cmc.2021.015436
|
| 46 |
Ishtiaqe Hanif, Mohammad Monirujjaman Khan. Liver Cirrhosis Prediction using Machine Learning Approaches. 2022 IEEE 13th Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON) 2022; : 0028 doi: 10.1109/UEMCON54665.2022.9965718
|
| 47 |
Iram Gull, Muhammad Shahbaz Aslam, Imran Tipu, Roohi Mushtaq, Tehseen Zamir Ali, Muhammad Amin Athar. Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47074-y
|
| 48 |
Chanbin Lee, Jinsol Han, Youngmi Jung. Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease. Biology 2022; 11(5): 637 doi: 10.3390/biology11050637
|
| 49 |
Monica Maia de Oliveira BARROS, Karla Regina Oliveira de Moura RONCHINI, Rosa Leonôra Salerno SOARES. HEPATITIS B AND C IN PREGNANT WOMEN ATTENDED BY A PRENATAL PROGRAM IN AN UNIVERSITARY HOSPITAL IN RIO DE JANEIRO, BRAZIL: RETROSPECTIVE STUDY OF SEROPREVALENCE SCREENING. Arquivos de Gastroenterologia 2018; 55(3): 267 doi: 10.1590/s0004-2803.201800000-68
|
| 50 |
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunology 2018; 31(4): 315 doi: 10.1089/vim.2017.0134
|
| 51 |
Liton Chandra Deb, Hannah Hove, Tracy K. Miller, Kodi Pinks, Grace Njau, John J. Hagan, Rick J. Jansen, Jee-Fu Huang. Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota. PLOS ONE 2022; 17(3): e0266047 doi: 10.1371/journal.pone.0266047
|
| 52 |
Gouda Kamel Helal, Magdy Abdelmawgoud Gad, Mohamed Fahmy Abd‐Ellah, Mahmoud Saied Eid. Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients. Journal of Medical Virology 2016; 88(12): 2170 doi: 10.1002/jmv.24575
|
| 53 |
Richard Y. Wang, Patricia Bare, Valeria De Giorgi, Kentaro Matsuura, Kazi Abdus Salam, Teresa Grandinetti, Cathy Schechterly, Harvey J. Alter. Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system. Hepatology 2016; 64(6): 1900 doi: 10.1002/hep.28842
|
| 54 |
Mahmoud Nasr, Khaled El-Bahnasy, M. Hamdy, Sanaa M. Kamal. A novel model based on non invasive methods for prediction of liver fibrosis. 2017 13th International Computer Engineering Conference (ICENCO) 2017; : 276 doi: 10.1109/ICENCO.2017.8289800
|
| 55 |
Wei Xuan, Dandan Song, Youyou Yan, Ming Yang, Yan Sun, Nicoletta Guaragnella. A Potential Role for Mitochondrial DNA in the Activation of Oxidative Stress and Inflammation in Liver Disease. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5835910
|
| 56 |
Mary Geitona, Hara Kousoulakou, Ioannis Goulis, Spilios Manolakopoulos, Themistoclis Vasiliadis, Dimitrios Christodoulou, Charalabos Gogos, Spyridon Dourakis, Ioannis George Koskinas, Alexandra Papadokostopoulou, Aris Lathouris, George Papatheodoridis. Managing Hepatitis C Patients in Greece: A Budget Impact Analysis of Simeprevir plus Pegylated Interferon/Ribavirin Regimen at Early Stages of the Disease. Health 2017; 9(11): 1482 doi: 10.4236/health.2017.911109
|
| 57 |
Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Subarna Roy, Sanjay H. Deshpande, Harsha V. Hegde. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective. Molecules 2022; 27(3): 1076 doi: 10.3390/molecules27031076
|
| 58 |
Mahzabeen Emu, Farjana Bintay Kamal, Salimur Choudhury, Thiago E. Alves de Oliveira. Assisting the Non-invasive Diagnosis of Liver Fibrosis Stages using Machine Learning Methods. 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2020; : 5382 doi: 10.1109/EMBC44109.2020.9176542
|
| 59 |
Amina Arif, Naeem Rashid, Muhammad Akhtar. Removal of N-terminal methionine of human interferon α-2b by co‐producing with Pyrococcus furiosus methionine aminopeptidase in Escherichia coli. Biologia 2021; 76(6): 1843 doi: 10.1007/s11756-021-00728-7
|
| 60 |
Jiyoung Lee, Stephanie T. Chan, Ja Yeon Kim, Jing-hsiung James Ou, Xiang-Jin Meng, Aleem Siddiqui, Guangxiang Luo. Hepatitis C Virus Induces the Ubiquitin-Editing Enzyme A20 via Depletion of the Transcription Factor Upstream Stimulatory Factor 1 To Support Its Replication. mBio 2019; 10(4) doi: 10.1128/mBio.01660-19
|
| 61 |
Christos Triantos, Christos Konstantakis, Paraskeui Tselekouni, Maria Kalafateli, Ioanna Aggeletopoulou, Spilios Manolakopoulos. Epidemiology of hepatitis C in Greece. World Journal of Gastroenterology 2016; 22(36): 8094-8102 doi: 10.3748/wjg.v22.i36.8094
|
| 62 |
Braira Wahid, Shazia Rafique, Komal Saleem, Amjad Ali, Muhammad Idrees. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load. Journal of Interferon & Cytokine Research 2018; 38(3): 122 doi: 10.1089/jir.2017.0129
|
| 63 |
Livia Salmi, Matteo Nazzareno Barbaglia, Carlo Smirne, Sara Bianco, Giulia Guaschino, Maria Grazia Stella Crobu, Rosalba Minisini, Mario Pirisi. Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis. The Open Rheumatology Journal 2018; 12(1): 279 doi: 10.2174/1874312901812010279
|
| 64 |
Ayooluwatomiwa Deborah Adekunle, Kathi L. Harp, Zaynab G. Al-Abdali, Agatha S. Critchfield, Sheila Barnhart, Kathleen T. Winter. Reported Barriers to Hepatitis C Treatment among Pregnant and Early-Parenting Mothers Undergoing Substance Use Disorder Treatment in One U.S. State. Infectious Disease Reports 2021; 14(1): 1 doi: 10.3390/idr14010001
|
| 65 |
Brittany B Dennis, Leen Naji, Yasmin Jajarmi, Aijaz Ahmed, Donghee Kim. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World Journal of Gastroenterology 2021; 27(29): 4818-4830 doi: 10.3748/wjg.v27.i29.4818
|
| 66 |
Suraj D. Serai, Meng Yin. Preclinical MRI of the Kidney. Methods in Molecular Biology 2021; 2216: 301 doi: 10.1007/978-1-0716-0978-1_18
|
| 67 |
Tara Beaulieu, Kanna Hayashi, Michael J. Milloy, Ekaterina Nosova, Kora DeBeck, Julio Montaner, Thomas Kerr, Lianping Ti. HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs. JAIDS Journal of Acquired Immune Deficiency Syndromes 2018; 78(1): 93 doi: 10.1097/QAI.0000000000001651
|
| 68 |
Poor response to direct-acting antiviral therapy in HCV-infected elderly population: a real-life cohort study based on GeneXpert® technology. Future Virology 2018; 13(7): 467 doi: 10.2217/fvl-2017-0158
|
| 69 |
Adita Ayu Permanasari, Chie Aoki-Utsubo, Tutik Sri Wahyuni, Lidya Tumewu, Myrna Adianti, Aty Widyawaruyanti, Hak Hotta, Achmad Fuad Hafid. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03408-w
|
| 70 |
Andrea Magri, Omar Mokrane, Kate Lauder, Arvind H. Patel, Daniele Castagnolo. Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV). Bioorganic & Medicinal Chemistry Letters 2019; 29(5): 724 doi: 10.1016/j.bmcl.2019.01.008
|
| 71 |
Umesh Kumar Lilhore, Poongodi Manoharan, Jasminder Kaur Sandhu, Sarita Simaiya, Surjeet Dalal, Abdullah M. Baqasah, Majed Alsafyani, Roobaea Alroobaea, Ismail Keshta, Kaamran Raahemifar. Hybrid model for precise hepatitis-C classification using improved random forest and SVM method. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36605-3
|
| 72 |
Ahmed M. Elshewey, Mahmoud Y. Shams, Sayed M. Tawfeek, Amal H. Alharbi, Abdelhameed Ibrahim, Abdelaziz A. Abdelhamid, Marwa M. Eid, Nima Khodadadi, Laith Abualigah, Doaa Sami Khafaga, Zahraa Tarek. Optimizing HCV Disease Prediction in Egypt: The hyOPTGB Framework. Diagnostics 2023; 13(22): 3439 doi: 10.3390/diagnostics13223439
|
| 73 |
Reham M. Dawood, Rehab I. Moustafa, Tawfeek H. Abdelhafez, Reem El-Shenawy, Yasmine El-Abd, Noha G. Bader El Din, Jean Dubuisson, Mostafa K. El Awady. A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4571-5
|
| 74 |
Lisa Townshend-Bulson, Elena Roik, Youssef Barbour, Dana J. T. Bruden, Chriss E. Homan, Hannah G. F. Espera, Timothy J. Stevenson, Annette M. Hewitt, Wileina Rhodes, James E. Gove, Julia N. Plotnik, Mary M. Snowball, John McGilvray, Brenna C. Simons, Janet M. Johnston, Brian J. McMahon, Kimberly Page. The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals. PLOS ONE 2021; 16(12): e0260970 doi: 10.1371/journal.pone.0260970
|
| 75 |
Catherine Paul, Lohit Khera, Rajeev Kaul. Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion. Archives of Virology 2019; 164(5): 1271 doi: 10.1007/s00705-019-04151-x
|
| 76 |
Jingyuan Zhang, Zhihong Huang, Xinkui Liu, Chao Wu, Wei Zhou, Peizhi Ye, Antony Stalin, Shan Lu, Yingying Tan, Zhishan Wu, Xiaotian Fan, Xiaomeng Zhang, Miaomiao Wang, Bingbing Li, Guoliang Cheng, Yanfang Mou, Jiarui Wu, Shibiao Wan. Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6213865
|
| 77 |
Abdulrahman Alduraywish, Mostafa Ragheb, Ibrahim Taher, Nageh Louis, Khaled Aldossari, Rania Kishk. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study. Scandinavian Journal of Gastroenterology 2020; 55(8): 963 doi: 10.1080/00365521.2020.1790649
|
| 78 |
Zara Naz, Braira Wahid, Sana Usman, Komal Saleem, Shazia Rafique, Amjad Ali, Muhammad Idrees. Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients. Journal of Interferon & Cytokine Research 2018; 38(6): 255 doi: 10.1089/jir.2017.0138
|